UK Connectivty Study

Help your patients improve their glycaemic management

Real world data analysis presented at the 2023 Diabetes UK Professional Conference1 shows that patients with type 2 diabetes have significant improvements in glycaemic management when using a blood glucose meter connected to the mySugr* app. 

After four months of using the mySugr app and a connected blood glucose meter, a statistically significant reduction in estimated HbA1c2 and a significant increase in the percentage of blood glucose measurements in range was observed.

With 4.7 million people in the UK living with type 2 diabetes, this real world data demonstrates the huge potential of the mySugr app3.

Download UK Connectivity Study

Woman using her smartphone

About the study

The aim of this study was to explore the impact of a blood glucose meter connected to the mySugr app in UK users with type 2 diabetes, as this population often shows reduced glycaemic outcomes and increased diabetes-related complications.

The retrospective analysis looked at 1,229 people from the UK, with both type 1 and type 2 diabetes, who used an Accu-Chek meter connected with the mySugr app. Of these, 52.64% had type 1 diabetes and 47.36% had type 2 diabetes.

Previous studies have shown an improvement in people with type 1 diabetes with the use of blood glucose monitors connected with mobile health apps, however, this study is the first to review the impact of the mySugr app for people with type 2 diabetes.

Results

Reduction of estimated HbA1c (eHbA1c) and improved glycaemic management

After 4 months of using the mySugr app with a connected blood glucose meter, a statistically significant reduction of 0.44% was observed in the eHbA1c in users with type 2 diabetes. Interestingly, a reduction was observed in eHbA1c after only one month of use.

Graph showing a reduction of estimated HbA1c (eHbA1c) and improved glycaemic management

Percentage of Measurements in Range (MiR)

The percentage of blood glucose MiR for mySugr users with type 2 diabetes significantly increased (6.93%; p<0.001) after starting to use mySugr and, as with the estimated HbA1c, this was observed after just one month of app usage. Improvements observed in the users with type 1 diabetes were in line with those seen in previous studies.

Graph showing percentage of Measurements in Range (MiR)

1. Ide C, Mayor R, Ruch B. Real World Data Analysis shows a significant improvement on glycemic management when using a blood glucose monitor connected with a mobile health application in UK users with type 2 diabetes. Diabetes UK Professional Conference 2023 poster session: 26-28 April, Liverpool, UK.

2. Nathan DM, Kuenen J, Borg R et al. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008 Aug;31(8):1473-8.

3. Diabetes UK. Number of people living with diabetes in the UK tops 5 million for the first time. April 2023. [Online]. Available at: https://www.diabetes.org.uk/about_us/news/number-people-living-diabetes-uk-tops-5-million-first-time#:~:text=Our%20new%20figures%20show%20that,2%20diabetes%20in%20the%20UK.

* You must be at least 18 years old to register for the Accu-Chek Account. Please see the manual for intended use.

Quotations sourced from recorded interviews as part of consultancy agreements with Roche Diabetes Care Limited in 2022.

Connect with an Accu-Chek representative

Do you have questions, or are you ready to see a demo? <br>Schedule a call, and we'll show you what we can do for you, your team, and your patients.

Request demo